Morphological Differentiation Towards Neuronal Phenotype of SH-SY5Y Neuroblastoma Cells by Estradiol, Retinoic Acid and Cholesterol

Neurochemical Research

Volumn 41, Issue 4, 2016, Pages 731-747

  Teppola, Heidi ^a   Sarkanen, Jertta Riina ^a   Jalonen, Tuula O ^b   Linne, Marja Leena ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b St George s University School of Medicine   (Grenada)

Author keywords

Brain derived neurotrophic factor; Cholesterol; Differentiation; Estradiol; Retinoic acid; SH SY5Y

Indexed keywords

ABRINEURIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLESTEROL; ESTRADIOL; POTASSIUM ION; RETINOIC ACID;

ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL GROWTH; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE FIBER GROWTH; NEURITE; NEUROBLASTOMA CELL; NEUROFILAMENT; PRIORITY JOURNAL; SYNAPSE VESICLE; TUMOR CELL LINE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; INTERMEDIATE FILAMENT; NEUROBLASTOMA; ULTRASTRUCTURE;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLESTEROL; ESTRADIOL; HUMANS; INTERMEDIATE FILAMENTS; NEUROBLASTOMA; NEURONS; SYNAPTIC VESICLES; TRETINOIN;

EID: 84945586344     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1743-6     Document Type: Article

References (116)

1. Duckett JW, Koop CE (1977) Neuroblastoma. Urol Clin N Am 4:285–295
2. Franks LM, Bollen A, Seeger RC et al (1997) Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer 79:2028–2035
3. Escobar MA, Grosfeld JL, Powell RL et al (2006) Long-term outcomes in patients with stage IV neuroblastoma. J Pediatr Surg 41:377–381
4. Biedler JL, Helson L, Spengler BA (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643–2652
5. Kuramoto T, Werrbach-Perez K, Perez-Polo JR et al (1981) Membrane properties of a human neuroblastoma II: effects of differentiation. J Neurosci Res 6:441–449
6. Cernaianu G, Brandmaier P, Scholz G et al (2008) All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit. J Pediatr Surg 43:1284–1294
7. Tojima T, Kobayashi S, Ito E (2003) Dual role of cyclic AMP-dependent protein kinase in neuritogenesis and synaptogenesis during neuronal differentiation. J Neurosci Res 74:829–837
8. Pahlman S, Odelstad L, Larsson E et al (1981) Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int J Cancer 28:583–589
9. Pahlman S, Ruusala AI, Abrahamsson L et al (1984) Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 14:135–144
10. Adem A, Mattsson ME, Nordberg A et al (1987) Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation. Brain Res 430:235–242
11. Jalonen T, Akerman KE (1988) Single transient potassium channels in human neuroblastoma cells induced to differentiate in vitro. Neurosci Lett 86:99–104
12. Guarneri P, Cascio C, Piccoli T et al (2000) Human neuroblastoma SH-SY5Y cell line: neurosteroid-producing cell line relying on cytoskeletal organization. J Neurosci Res 60:656–665
13. Presgraves SP, Ahmed T, Borwege S et al (2004) Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res 5:579–598
14. Preis PN, Saya H, Nadasdi L et al (1988) Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A. Cancer Res 48:6530–6534
15. Toselli M, Tosetti P, Taglietti V (1996) Functional changes in sodium conductances in the human neuroblastoma cell line SH-SY5Y during in vitro differentiation. J Neurophysiol 76:3920–3927
16. Cheung YT, Lau WK, Yu MS et al (2009) Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30:127–135
17. Spina MB, Squinto SP, Miller J et al (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem 59:99–106
18. Encinas M, Iglesias M, Liu Y et al (2000) Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75:991–1003
19. Goldie BJ, Barnett MM, Cairns MJ (2014) BDNF and the maturation of posttranscriptional regulatory networks in human SH-SY5Y neuroblast differentiation. Front Cell Neurosci 8:325
20. Rogers MV, Buensuceso C, Montague F et al (1994) Vanadate stimulates differentiation and neurite outgrowth in rat pheochromocytoma PC12 cells and neurite extension in human neuroblastoma SH-SY5Y cells. Neuroscience 60:479–494
21. Lavenius E, Gestblom C, Johansson I et al (1995) Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor. Cell Growth Differ 6:727–736
22. Oe T, Sasayama T, Nagashima T et al (2005) Differences in gene expression profile among SH-SY5Y neuroblastoma subclones with different neurite outgrowth responses to nerve growth factor. J Neurochem 94:1264–1276
23. Sarkanen JR, Nykky J, Siikanen J et al (2007) Cholesterol supports the retinoic acid-induced synaptic vesicle formation in differentiating human SH-SY5Y neuroblastoma cells. J Neurochem 102:1941–1952
24. Agholme L, Lindstrom T, Kagedal K et al (2010) An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J Alzheimers Dis 20:1069–1082
25. Szutowicz A, Bielarczyk H, Jankowska-Kulawy A et al (2015) Retinoic acid as a therapeutic option in Alzheimer’s disease: a focus on cholinergic restoration. Expert Rev Neurother 15:239–249
26. Sidell N, Lucas CA, Kreutzberg GW (1984) Regulation of acetylcholinesterase activity by retinoic acid in a human neuroblastoma cell line. Exp Cell Res 155:305–309
27. Stio M, Celli A, Treves C (2001) Synergistic anti-proliferative effects of vitamin D derivatives and 9-cis retinoic acid in SH-SY5Y human neuroblastoma cells. J Steroid Biochem Mol Biol 77:213–222
28. Matthay KK, Reynolds CP, Seeger RC et al (2009) Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children’s oncology group study. J Clin Oncol 27:1007–1013
29. Adamson PC, Matthay KK, O’Brien M et al (2007) A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or wilms tumor: a pediatric oncology branch, NCI and children’s oncology group study. Pediatr Blood Cancer 49:661–665
30. Mauch DH, Nagler K, Schumacher S et al (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294:1354–1357
31. Chen J, Costa LG, Guizzetti M (2011) Assessment of cholesterol homeostasis in astrocytes and neurons. Methods Mol Biol 758:403–414
32. Goritz C, Mauch DH, Pfrieger FW (2005) Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol Cell Neurosci 29:190–201
33. Ullian EM, Harris BT, Wu A et al (2004) Schwann cells and astrocytes induce synapse formation by spinal motor neurons in culture. Mol Cell Neurosci 25:241–251
34. Koudinov AR, Koudinova NV (2001) Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J 15:1858–1860
35. Pfrieger FW (2003) Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? BioEssays 25:72–78
36. Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677–736
37. Kaplan DR, Matsumoto K, Lucarelli E et al (1993) Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic signal transduction group. Neuron 11:321–331
38. Ho R, Eggert A, Hishiki T et al (2002) Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res 62:6462–6466
39. Low WC, Rujitanaroj PO, Wang F et al (2015) Nanofiber-mediated release of retinoic acid and brain-derived neurotrophic factor for enhanced neuronal differentiation of neural progenitor cells. Drug Deliv Transl Res 5:89–100
40. Ferrer I, Goutan E, Marin C et al (2000) Brain-derived neurotrophic factor in huntington disease. Brain Res 866:257–261
41. Murer MG, Yan Q, Raisman-Vozari R (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease. Prog Neurobiol 63:71–124
42. Phillips HS, Hains JM, Armanini M et al (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron 7:695–702
43. Gould E, Woolley CS, Frankfurt M et al (1990) Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 10:1286–1291
44. McEwen BS, Coirini H, Schumacher M (1990) Steroid effects on neuronal activity: When is the genome involved? Ciba Found Symp 153:3–12 (discussion 12–21)
45. Woolley CS, Gould E, Frankfurt M et al (1990) Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 10:4035–4039
46. Wong M, Moss RL (1992) Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J Neurosci 12:3217–3225
47. Wong M, Moss RL (1991) Electrophysiological evidence for a rapid membrane action of the gonadal steroid, 17 beta-estradiol, on CA1 pyramidal neurons of the rat hippocampus. Brain Res 543:148–152
48. Chamniansawat S, Chongthammakun S (2009) Estrogen stimulates activity-regulated cytoskeleton associated protein (arc) expression via the MAPK- and PI-3K-dependent pathways in SH-SY5Y cells. Neurosci Lett 452:130–135
49. Chindewa R, Lapanantasin S, Sanvarinda Y et al (2008) Pueraria mirifica, phytoestrogen-induced change in synaptophysin expression via estrogen receptor in rat hippocampal neuron. J Med Assoc Thai 91:208–214
50. Jelks KB, Wylie R, Floyd CL et al (2007) Estradiol targets synaptic proteins to induce glutamatergic synapse formation in cultured hippocampal neurons: critical role of estrogen receptor-alpha. J Neurosci 27:6903–6913
51. Liu F, Day M, Muniz LC et al (2008) Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci 11:334–343
52. Xu X, Zhang Z (2006) Effects of estradiol benzoate on learning-memory behavior and synaptic structure in ovariectomized mice. Life Sci 79:1553–1560
53. Babayan AH, Kramar EA (2013) Rapid effects of oestrogen on synaptic plasticity: interactions with actin and its signalling proteins. J Neuroendocrinol 25:1163–1172
54. Kretz O, Fester L, Wehrenberg U et al (2004) Hippocampal synapses depend on hippocampal estrogen synthesis. J Neurosci 24:5913–5921
55. Prange-Kiel J, Wehrenberg U, Jarry H et al (2003) Para/autocrine regulation of estrogen receptors in hippocampal neurons. Hippocampus 13:226–234
56. Woolley CS, McEwen BS (1994) Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 14:7680–7687
57. Weiland NG (1992) Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology 131:662–668
58. Warren SG, Humphreys AG, Juraska JM et al (1995) LTP varies across the estrous cycle: enhanced synaptic plasticity in proestrus rats. Brain Res 703:26–30
59. Good M, Day M, Muir JL (1999) Cyclical changes in endogenous levels of oestrogen modulate the induction of LTD and LTP in the hippocampal CA1 region. Eur J Neurosci 11:4476–4480
60. Gazzaley AH, Weiland NG, McEwen BS et al (1996) Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J Neurosci 16:6830–6838
61. Cyr M, Ghribi O, Thibault C et al (2001) Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors. Brain Res Brain Res Rev 37:153–161
62. Cyr M, Ghribi O, Di Paolo T (2000) Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain. J Neuroendocrinol 12:445–452
63. Bi R, Foy MR, Vouimba RM et al (2001) Cyclic changes in estradiol regulate synaptic plasticity through the MAP kinase pathway. Proc Natl Acad Sci U S A 98:13391–13395
64. Cordoba Montoya DA, Carrer HF (1997) Estrogen facilitates induction of long term potentiation in the hippocampus of awake rats. Brain Res 778:430–438
65. Woolley CS, Weiland NG, McEwen BS et al (1997) Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci 17:1848–1859
66. Rudick CN, Woolley CS (2001) Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci 21:6532–6543
67. Smith CC, McMahon LL (2005) Estrogen-induced increase in the magnitude of long-term potentiation occurs only when the ratio of NMDA transmission to AMPA transmission is increased. J Neurosci 25:7780–7791
68. Kuiper GG, Enmark E, Pelto-Huikko M et al (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 93:5925–5930
69. Levin ER (2005) Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 19:1951–1959
70. Akama KT, McEwen BS (2003) Estrogen stimulates postsynaptic density-95 rapid protein synthesis via the akt/protein kinase B pathway. J Neurosci 23:2333–2339
71. Waters EM, Mitterling K, Spencer JL et al (2009) Estrogen receptor alpha and beta specific agonists regulate expression of synaptic proteins in rat hippocampus. Brain Res 1290:1–11
72. Marino M, Galluzzo P, Ascenzi P (2006) Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics 7:497–508
73. Ivanova T, Mendez P, Garcia-Segura LM et al (2002) Rapid stimulation of the PI3-kinase/akt signalling pathway in developing midbrain neurones by oestrogen. J Neuroendocrinol 14:73–79
74. Mannella P, Brinton RD (2006) Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated akt and extracellular signal-regulated kinase 1/2 in the same population of cortical neurons: a unified mechanism of estrogen action. J Neurosci 26:9439–9447
75. Bang OY, Hong HS, Kim DH et al (2004) Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity. Neurobiol Dis 16:21–28
76. Steward O, Worley PF (2001) A cellular mechanism for targeting newly synthesized mRNAs to synaptic sites on dendrites. Proc Natl Acad Sci U S A 98:7062–7068
77. Guzowski JF, Lyford GL, Stevenson GD et al (2000) Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J Neurosci 20:3993–4001
78. Guzowski JF, Setlow B, Wagner EK et al (2001) Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes arc, c-fos, and zif268. J Neurosci 21:5089–5098
79. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675
80. Gavet O, Pines J (2010) Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell 18:533–543
81. Burgess A, Vigneron S, Brioudes E et al (2010) Loss of human greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci U S A 107:12564–12569
82. Selinummi J, Seppala J, Yli-Harja O et al (2005) Software for quantification of labeled bacteria from digital microscope images by automated image analysis. Biotechniques 39:859–863
83. Fanti Z, De-Miguel FF, Martinez-Perez ME (2008) A method for semiautomatic tracing and morphological measuring of neurite outgrowth from DIC sequences. Conf Proc IEEE Eng Med Biol Soc 2008:1196–1199
84. Croft BG, Fortin GD, Corera AT et al (2005) Normal biogenesis and cycling of empty synaptic vesicles in dopamine neurons of vesicular monoamine transporter 2 knockout mice. Mol Biol Cell 16:306–315
85. Pyle JL, Kavalali ET, Choi S et al (1999) Visualization of synaptic activity in hippocampal slices with FM1-43 enabled by fluorescence quenching. Neuron 24:803–808
86. Biagiotti T, D’Amico M, Marzi I et al (2006) Cell renewing in neuroblastoma: electrophysiological and immunocytochemical characterization of stem cells and derivatives. Stem Cells 24:443–453
87. Daniele F, Di Cairano ES, Moretti S et al (2015) TIRFM and pH-sensitive GFP-probes to evaluate neurotransmitter vesicle dynamics in SH-SY5Y neuroblastoma cells: Cell imaging and data analysis. J Vis Exp (95). doi:10.3791/52267
88. Simon T, Berthold F, Borkhardt A et al (2011) Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of german trials. Pediatr Blood Cancer 56:578–583
89. Berthold F, Boos J, Burdach S et al (2005) Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. Lancet Oncol 6:649–658
90. Matthay KK, Villablanca JG, Seeger RC et al (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s cancer group. N Engl J Med 341:1165–1173
91. Pearson AD, Pinkerton CR, Lewis IJ et al (2008) High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial. Lancet Oncol 9:247–256
92. Nakamura K, Martin KC, Jackson JK et al (2006) Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res 66:4249–4255
93. Acheson A, Conover JC, Fandl JP et al (1995) A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374:450–453
94. Jaboin J, Kim CJ, Kaplan DR et al (2002) Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3’-kinase pathway. Cancer Res 62:6756–6763
95. Matsumoto K, Wada RK, Yamashiro JM et al (1995) Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res 55:1798–1806
96. Nakagawara A, Azar CG, Scavarda NJ et al (1994) Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 14:759–767
97. Nishida Y, Adati N, Ozawa R et al (2008) Identification and classification of genes regulated by phosphatidylinositol 3-kinase- and TRKB-mediated signalling pathways during neuronal differentiation in two subtypes of the human neuroblastoma cell line SH-SY5Y. BMC Res. Notes 1:95-0500-1-95
98. Takahashi K, Piao S, Yamatani H et al (2011) Estrogen induces neurite outgrowth via rho family GTPases in neuroblastoma cells. Mol Cell Neurosci 48:217–224
99. Muley PD, McNeill EM, Marzinke MA et al (2008) The atRA-responsive gene neuron navigator 2 functions in neurite outgrowth and axonal elongation. Dev Neurobiol 68:1441–1453
100. Fryer RH, Kaplan DR, Kromer LF (1997) Truncated trkB receptors on nonneuronal cells inhibit BDNF-induced neurite outgrowth in vitro. Exp Neurol 148:616–627
101. Messi E, Florian MC, Caccia C et al (2008) Retinoic acid reduces human neuroblastoma cell migration and invasiveness: effects on DCX, LIS1, neurofilaments-68 and vimentin expression. BMC Cancer 8:30-2407-8-30
102. Rebhan M, Vacun G, Bayreuther K et al (1994) Altered ganglioside expression by SH-SY5Y cells upon retinoic acid-induced neuronal differentiation. NeuroReport 5:941–944
103. Hu R, Cai WQ, Wu XG et al (2007) Astrocyte-derived estrogen enhances synapse formation and synaptic transmission between cultured neonatal rat cortical neurons. Neuroscience 144:1229–1240
104. Sodhi RK, Singh N (2014) Retinoids as potential targets for Alzheimer’s disease. Pharmacol Biochem Behav 120:117–123
105. Pfrieger FW (2003) Role of cholesterol in synapse formation and function. Biochim Biophys Acta 1610:271–280
106. Deutsch JW, Kelly RB (1981) Lipids of synaptic vesicles: relevance to the mechanism of membrane fusion. Biochemistry 20:378–385
107. Linetti A, Fratangeli A, Taverna E et al (2010) Cholesterol reduction impairs exocytosis of synaptic vesicles. J Cell Sci 123:595–605
108. Smith AJ, Sugita S, Charlton MP (2010) Cholesterol-dependent kinase activity regulates transmitter release from cerebellar synapses. J Neurosci 30:6116–6121
109. Renner M, Choquet D, Triller A (2009) Control of the postsynaptic membrane viscosity. J Neurosci 29:2926–2937
110. Aoto J, Nam CI, Poon MM et al (2008) Synaptic signaling by all-trans retinoic acid in homeostatic synaptic plasticity. Neuron 60:308–320
111. Davis GW (2006) Homeostatic control of neural activity: from phenomenology to molecular design. Annu Rev Neurosci 29:307–323
112. Rich MM, Wenner P (2007) Sensing and expressing homeostatic synaptic plasticity. Trends Neurosci 30:119–125
113. Kramar EA, Babayan AH, Gall CM et al (2013) Estrogen promotes learning-related plasticity by modifying the synaptic cytoskeleton. Neuroscience 239:3–16
114. Fester L, Zhou L, Butow A et al (2009) Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus. Hippocampus 19:692–705
115. Nilsen J, Mor G, Naftolin F (1998) Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells. Menopause 5:211–216
116. Chen G, Li HM, Chen YR et al (2007) Decreased estradiol release from astrocytes contributes to the neurodegeneration in a mouse model of niemann-pick disease type C. Glia 55:1509–1518